Pangaea Data is Attending the JPM Healthcare Conference

JAMIA Publication:The Potential and Pitfalls of using a LLM as a Clinical Assistant

Full Steam Ahead: How AI Can Transform the Genetics Journey in Precision Medicine

Pangaea Data Selected for NVIDIA & Microsoft’s New AI Initiative

From Thin Ice to Solid Ground: How AI is Changing Clinical Practice for the Better

GO BACK

AI Configured on Clinical Guidelines to Find More Untreated Cachectic Cancer Patients

9:00-10:00AM PT, October 20th, Disco Stage, Las Vegas, NV, USA

Presentation

Session: AI in Action: The UK Experience

Location: Disco Stage

Pangaea will be presenting on how the UK’s NHS has applied Pangaea’s platform, PALLUX, to find 6x more untreated cachectic cancer patients for treatment and trials, helping to lead to 50% lower treatment costs and a potential annual savings of £1 Billion for the NHS.

Demo Station

Dates: October 21st – 23rd

Location: UK Department for Business & Trade Pavilion (#1754-13)

Learn about Pangaea’s AI platform, PALLUX, which is configured on clinical guidelines to find more untreated (undiagnosed, misdiagnosed, miscoded, at-risk, uncontrolled) and under-treated patients for hard-to-diagnose conditions at the point of care for treatment and trials. This helps to find more suitable patients who would otherwise be missed despite the information available in their records, due to treatment for other conditions or administrative reasons.

Please let us know if you are available to meet by registering through the form below or emailing us at info@pangaeadata.ai

Register to Meet Us

Attendees

Dr. Vibhor Gupta
Founder,
Pangaea Data
Dr. David Everman
Clinical Scientist,
Pangaea Data